Literature DB >> 8163058

Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

A J Jaap1, M S Hammersley, A C Shore, J E Tooke.   

Abstract

Abnormalities of microvascular function may be important in the pathogenesis of diabetic microangiopathy. As such changes are already present at diagnosis in patients with Type 2 (non-insulin-dependent) diabetes mellitus, subjects at risk of developing the disease, who had elevated fasting plasma glucose concentrations below the diabetic range, were studied. The maximal microvascular hyperaemic response to local heating was determined in the feet of 11 subjects with fasting hyperglycaemia and 11 age- and sex-matched control subjects. There was reduced maximal hyperaemia in the subjects with fasting hyperglycaemia (1.01 [0.71-1.57]V, median and range), when compared to control subjects (1.41 [1.32-2.13]V, p < 0.001). It is unlikely that this limited vasodilation is a result of the mild degree of hyperglycaemia observed in the subjects included in this study. Further studies are therefore required to address the possible mechanisms of limited microvascular reactivity in subjects at risk of developing Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163058     DOI: 10.1007/s001250050096

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

1.  Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patients.

Authors:  D D Sandeman; C A Pym; E M Green; C Seamark; A C Shore; J E Tooke
Journal:  BMJ       Date:  1991-05-11

Review 2.  Microvascular haemodynamics in diabetes mellitus.

Authors:  J E Tooke
Journal:  Clin Sci (Lond)       Date:  1986-02       Impact factor: 6.124

3.  UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors.

Authors: 
Journal:  Diabetes Res       Date:  1990-01

4.  Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group.

Authors: 
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

5.  Skin reactive hyperemia in diabetic patients. A study by laser Doppler flowmetry.

Authors:  E Tur; G Yosipovitch; Y Bar-On
Journal:  Diabetes Care       Date:  1991-11       Impact factor: 19.112

6.  Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes.

Authors:  G Rayman; S A Williams; P D Spencer; L H Smaje; P H Wise; J E Tooke
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

7.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

8.  Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease.

Authors:  R W Stout
Journal:  Am J Med       Date:  1991-02-21       Impact factor: 4.965

  8 in total
  25 in total

Review 1.  Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication.

Authors:  Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

Review 2.  The role of endothelial insulin signaling in the regulation of glucose metabolism.

Authors:  Tetsuya Kubota; Naoto Kubota; Takashi Kadowaki
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

3.  Combining laser-Doppler flowmetry measurements with spectral analysis to study different microcirculatory effects in human prediabetic and diabetic subjects.

Authors:  Hsiao-Feng Hu; Hsin Hsiu; Ciao-Jyuan Sung; Chien-Hsing Lee
Journal:  Lasers Med Sci       Date:  2016-12-07       Impact factor: 3.161

4.  The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin.

Authors:  J E Tooke; L M Elston; K M Gooding; C I Ball; D M Mawson; J Piper; R Sriraman; R Urquhart; A C Shore
Journal:  Diabetologia       Date:  2006-03-01       Impact factor: 10.122

5.  Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats.

Authors:  Christopher G Ellis; Daniel Goldman; Madelyn Hanson; Alan H Stephenson; Stephanie Milkovich; Amina Benlamri; Mary L Ellsworth; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-05       Impact factor: 4.733

6.  2009 World Congress on the Insulin Resistance Syndrome: cardiovascular disease concepts.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

7.  Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes.

Authors:  P-A Jansson; G Murdolo; L Sjögren; B Nyström; M Sjöstrand; L Strindberg; P Lönnroth
Journal:  Diabetologia       Date:  2010-06-10       Impact factor: 10.122

8.  Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes?

Authors:  T Y Wong; Q Mohamed; R Klein; D J Couper
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

9.  Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM.

Authors:  S J Morris; A C Shore; J E Tooke
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

10.  Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes.

Authors:  Nikolaos Ostlund Papadogeorgos; Mattias Bengtsson; Majid Kalani
Journal:  Vasc Health Risk Manag       Date:  2009-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.